Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Taylor

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 31, 1997
Lymphokine-activated killer (LAK)-mediated lysis of sequentially isolated ovarian cancer cell linesC M Yashar, D D Taylor, R K Gibb, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 1998
Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patientsS R Chinni, C Gerçel-Taylor, G E Conner, et al.
Gynecologic Oncology|July 27, 1999
Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancerL B Bazzett, C S Watkins, C Gercel-Taylor, et al.
International Journal of Cancer|April 15, 1988
Characterization of plasma membrane shedding from murine melanoma cellsD D Taylor, C G Taylor, C G Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesiclesD D Poutsiaka, D D Taylor, E M Levy, et al.
The Journal of Surgical Research|May 1, 1986
Demonstration of lipolytic activity from cultured human melanoma cellsD M Hollander, D F Devereux, C G Taylor, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 14, 2007
Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatmentS M Shondel, C W Helm, C Gercel-Taylor, et al.
Gynecologic Oncology|January 1, 1996
Aberrations in normal systemic lipid metabolism in ovarian cancer patientsC Gercel-Taylor, D L Doering, F B Kraemer, et al.
Cancer Research|February 15, 1992
Identification of a human tumor-derived lipolysis-promoting factorD D Taylor, C Gercel-Taylor, L G Jenis, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Enhancement of antitumor effects of combined chemoimmunotherapyD D Taylor, C Gerçel-Taylor, W C Fowler, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 31, 1997
Lymphokine-activated killer (LAK)-mediated lysis of sequentially isolated ovarian cancer cell linesC M Yashar, D D Taylor, R K Gibb, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 1998
Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patientsS R Chinni, C Gerçel-Taylor, G E Conner, et al.
Gynecologic Oncology|July 27, 1999
Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancerL B Bazzett, C S Watkins, C Gercel-Taylor, et al.
International Journal of Cancer|April 15, 1988
Characterization of plasma membrane shedding from murine melanoma cellsD D Taylor, C G Taylor, C G Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesiclesD D Poutsiaka, D D Taylor, E M Levy, et al.
The Journal of Surgical Research|May 1, 1986
Demonstration of lipolytic activity from cultured human melanoma cellsD M Hollander, D F Devereux, C G Taylor, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 14, 2007
Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatmentS M Shondel, C W Helm, C Gercel-Taylor, et al.
Gynecologic Oncology|January 1, 1996
Aberrations in normal systemic lipid metabolism in ovarian cancer patientsC Gercel-Taylor, D L Doering, F B Kraemer, et al.
Cancer Research|February 15, 1992
Identification of a human tumor-derived lipolysis-promoting factorD D Taylor, C Gercel-Taylor, L G Jenis, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Enhancement of antitumor effects of combined chemoimmunotherapyD D Taylor, C Gerçel-Taylor, W C Fowler, et al.
Pageof 8